Raisio, Finland

Mikko Kuoppamäki

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Orion Corporation. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mikko Kuoppamäki. Retrieved from https://idiyas.com/inventor/mikko-kuoppamäki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mikko Kuoppamäki: Innovator in Parkinson's Disease Treatment

Introduction

Mikko Kuoppamäki is a notable inventor based in Raisio, Finland. He has made significant contributions to the field of medicine, particularly in the treatment of Parkinson's disease. With a total of 3 patents, his work has the potential to improve the lives of many patients suffering from this condition.

Latest Patents

One of his latest patents focuses on the use of levodopa, carbidopa, and entacapone for treating Parkinson's disease. The present disclosure provides a method for the treatment of Parkinson's disease comprising simultaneously or sequentially administering to a patient in need of treatment a dosage form that includes these compounds. This innovative approach aims to enhance the effectiveness of the treatment regimen for patients.

Career Highlights

Mikko Kuoppamäki is associated with Orion Corporation, a leading pharmaceutical company in Finland. His work at Orion has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in neurology.

Collaborations

Some of his notable coworkers include Juha Rouru and Juha Ellmen. Their combined expertise has fostered a collaborative environment that encourages innovation and the development of new treatment methods.

Conclusion

Mikko Kuoppamäki's contributions to the treatment of Parkinson's disease through his patents and work at Orion Corporation highlight his dedication to improving patient care. His innovative approaches continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…